Elan Corp. plc buy melinda
Start price
22.01.12
/
50%
€10.39
Target price
23.07.12
€13.00
Performance (%)
10.29%
End price
23.07.12
€11.45
Summary
This prediction ended on 23.07.12 with a price of €11.45. The BUY prediction by melinda finished with a performance of 10.29%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Elan Corp. plc | - | - | - | - |
iShares Core DAX® | -3.935% | -3.998% | 11.192% | 10.824% |
iShares Nasdaq 100 | -3.608% | -9.386% | 22.243% | 34.145% |
iShares Nikkei 225® | -4.513% | -8.017% | 5.961% | 2.360% |
iShares S&P 500 | -2.607% | -4.265% | 21.865% | 36.823% |
Comments by melinda for this prediction
In the thread Elan Corp. plc diskutieren
multiple Sklerose
Elan Corp of Food and Drug Administration aktualisiert die Kennzeichnung von individuellen Beurteilung Tysabri für Patienten mit Multipler Sklerose
(Laufzeit überschritten)